Date
Therapeutic and Clinical Areas
Topics
Content Type
Asset Type
Product Brands
Product Families
Product Categories
Product Line
Showing 1 to 10 of 46 results
- LAST UPDATE: Jul 26, 2024AdvertisementHere, Victoria Meyer, Senior Global Strategic Marketing Manager at BD Medical – Pharmaceutical Systems, introduces the BD SCF™ PremiumCoat® 1mlL Plunger Stopper and explains how the product’s role is critical in determining combination products’ exposure to extractables and leachables.
- LAST UPDATE: Jul 18, 2024BrochureLearn about technical services at BDM-PS.
- LAST UPDATE: Jul 18, 2024BrochureLearn about general services at BDM-PS.
- LAST UPDATE: Jul 18, 2024BrochureThis interactive brochure introduces a comprehensive set of services and solutions designed to mitigate the risks associated with combination product development to help you achieve your goals. These services and solutions help you from development all the way through to launch, including container selection, combination product expertise and testing, regulatory and technical documentation support, analytical testing, world class lab capabilities, ongoing consultation, and more.
- LAST UPDATE: Jul 18, 2024BrochureLearn about general services at BDM-PS.
- LAST UPDATE: Jul 18, 2024Brochure"Learn about the BD Hypak™ for Biotech Glass Prefillable Syringe. Grounded on decades of BD Hypak™ experience, BD Hypak™ for Biotech has been developed to address the key compatibility challenges for biotech drugs and chronic treatments. "
- LAST UPDATE: Jul 18, 2024BrochureThis brochure describes the BD Accelerate program which is a drug development support program that helps you rapidly access small quantities of BD’s validated prefillable syringe systems and safety & shielding solutions to meet your immediate needs.
- LAST UPDATE: Jul 18, 2024Scientific PosterAs high dose biologic formulations push the limits of self injection into 1 2 ml formats and beyond, delivery systems that are intuitive and easy to use, and targeted to specific user populations, are becoming increasingly necessary.
- LAST UPDATE: Jul 18, 2024Promotional ArticleTo support the successful transition to decentralized clinical trials, BD is developing a new, connected injection device designed to meet the needs of each stakeholder group (participants, trial sponsors and contract research organizations (CROs) undertaking decentralized clinical trials (DCTs) or hybrid clinical trials.
- LAST UPDATE: Jul 18, 2024Promotional ArticleThrough this interview, learn about product and clinician needs in delivering Hyaluronic Acid (HA) for cosmetic applications. Sagar Bejalwar is a Global Marketing Manager at BD Medical—Pharmaceutical Systems, where his responsibilities include developing prefillable syringe solutions that most closely address drug, product manufacturer and clinician needs.